Bladder cancer ranks among the most common cancers globally. At diagnosis, 75% of
patients have non-muscle-invasive bladder cancer (NMIBC). Patients with low-risk NMIBC …

Bladder cancer (BC) constitutes one of the most diagnosed types of cancer worldwide.
Advancements in and new methodologies for DNA sequencing, leading to high-throughput …

Microbiota colonize exposed body tissues (eg, gastrointestinal tract, skin, lungs, female
genital tract, and urogenital tracts) and unexposed sites (eg, breast). Persistent bacterial …

A growing body of evidence suggests that cancer remains a significant global health
challenge, necessitating the development of novel therapeutic approaches. In recent years …

Purpose The recent discovery of the urinary microbiome has led to an emerging field of
investigation about the potential role of microorganisms in the pathogenesis of urinary …

The burgeoning field of pharmacomicrobiomics offers promising insights into the intricate
interplay between the microbiome and cancer, shaping responses to diverse treatment …

Urinary bladder cancer (BC) inflicts a significant impairment of life quality and poses a high
mortality risk. Schistosoma haematobium infection can cause BC, and the urinary microbiota …

Background Radical cystectomy and urinary diversion (UD) are gold standards for non-
metastatic muscle-invasive bladder cancer. Orthotopic neobladder (or Studer), ileal conduit …

The maintenance of homeostasis can be influenced by the gut microbiota. An imbalance in
the gut microbiota, known as gut microbiota dysbiosis, can result in the deterioration of the …

It is a challenge to assemble an enormous amount of metagenome data in metagenomics.
Usually, metagenome cluster sequence before assembly accelerates the whole process. In …